NCT01165125View on ClinicalTrials.gov

A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 1, 2010

Primary Completion Date

August 28, 2010

Study Completion Date

August 28, 2010

Conditions

Asthma

Interventions

DRUG

FF / GW642444

200mcg/25mcg Novel DPI

DRUG

ketoconazole

400mcg overencapsulated tablets

DRUG

ketoconazole (placebo to match)

placebo to match overencapsulated tablets

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01165125 - A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole | Biotech Hunter | Biotech Hunter